KORU Medical Systems (NASDAQ:KRMD – Get Free Report) and Schrodinger (NASDAQ:SDGR – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations and profitability.
Insider and Institutional Ownership
58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares KORU Medical Systems and Schrodinger”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| KORU Medical Systems | $43.26 million | 4.60 | -$2.64 million | ($0.05) | -86.70 |
| Schrodinger | $255.87 million | 5.01 | -$103.26 million | ($1.41) | -12.32 |
KORU Medical Systems has higher earnings, but lower revenue than Schrodinger. KORU Medical Systems is trading at a lower price-to-earnings ratio than Schrodinger, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
KORU Medical Systems has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500. Comparatively, Schrodinger has a beta of 1.64, indicating that its share price is 64% more volatile than the S&P 500.
Profitability
This table compares KORU Medical Systems and Schrodinger’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| KORU Medical Systems | -5.27% | -13.61% | -8.33% |
| Schrodinger | -40.61% | -30.85% | -15.32% |
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for KORU Medical Systems and Schrodinger, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| KORU Medical Systems | 1 | 0 | 4 | 0 | 2.60 |
| Schrodinger | 1 | 4 | 4 | 0 | 2.33 |
KORU Medical Systems presently has a consensus price target of $7.25, suggesting a potential upside of 67.24%. Schrodinger has a consensus price target of $20.25, suggesting a potential upside of 16.58%. Given KORU Medical Systems’ stronger consensus rating and higher probable upside, equities research analysts plainly believe KORU Medical Systems is more favorable than Schrodinger.
Summary
KORU Medical Systems beats Schrodinger on 8 of the 13 factors compared between the two stocks.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
About Schrodinger
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
